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Abstract
Exposure to extreme stress can trigger the development of major depressive disorder
(MDD) as well as post-traumatic stress disorder (PTSD). The molecular mechanisms under-
lying the structural and functional alterations within corticolimbic brain regions, including the
prefrontal cortex (PFC) and amygdala of individuals subjected to traumatic stress, remain
unknown. In this study, we show that serum and glucocorticoid regulated kinase 1 (SGK1)
expression is down-regulated in the postmortem PFC of PTSD subjects. Furthermore, we
demonstrate that inhibition of SGK1 in the rat medial PFC results in helplessness- and
anhedonic-like behaviors in rodent models. These behavioral changes are accompanied by
abnormal dendritic spine morphology and synaptic dysfunction. Together, the results are
consistent with the possibility that altered SGK1 signaling contributes to the behavioral and
morphological phenotypes associated with traumatic stress pathophysiology.
Author Summary
Improper functioning of the brain regions known as prefrontal cortex and amygdala is
associated with the development of post-traumatic stress disorder. However, little is
known about the molecular mechanisms that underlie this condition. We found that the
expression of a protein kinase involved in cellular responses to stress, known as serum and
glucocorticoid regulated kinase 1 (SGK1), was decreased in the prefrontal cortex of sub-
jects who had died with post-traumatic stress disorder. Furthermore, we found that
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experimentally decreasing SGK1 function in the prefrontal cortex of rats resulted in behav-
iors characteristic of traumatic stress, including the unwillingness to avoid discomfort and
the inability to experience pleasure. Finally, reduced SGK1 function in neurons affected
their basic electrophysiological properties and caused a decrease in the number of den-
dritic spines—the specialized protrusions of dendrites that receive synaptic inputs.
Introduction
Major depressive disorder (MDD) and post-traumatic stress disorder (PTSD) are highly
comorbid. Approximately 50% of newly diagnosed patients with PTSD meet criteria for MDD
[1]. Exposure to traumatic stress is an important factor in the etiology of both, MDD and
PTSD. Regardless of the type of trauma, symptoms include increased fear and anxiety, intrusive
thoughts and dreams of the trauma, conditioned fear and hyperarousal including increased
startle response, avoidance of reminders of the trauma, and emotional numbing and anhedonia
[2,3]. Neuroimaging studies in PTSD patients show an impaired function of medial prefrontal
cortex (mPFC) [4–6], resulting in decreased inhibitory control of amygdala function that con-
tributes to increased anxiety and fear [7–9]. This general pattern of brain circuit dysfunction
also emerges in healthy humans exposed to uncontrollable stress [10]. Decreased responsive-
ness of the mPFC leads to deficits in the ability to extinguish fear responses, which contributes
to the persistence of traumatic memories seen in patients with PTSD [7,8,11].
Inescapable stress, originally recognized as an animal model for depression, produces a syn-
drome that shares many behavioral, physiologic, and neurochemical features observed in
MDD and PTSD [12–15]. In addition, morphological studies conducted in rodent mPFC show
that chronic stress causes a reduction of dendrite length and spine density of pyramidal neu-
rons, and these alterations are associated with impairments in mPFC-mediated cognitive tasks
[16].
Despite this progress on circuit level analysis of PTSD pathophysiology, there is very little
known about the underlying molecular and cellular alterations that cause PTSD. To address
this issue, we have established the first PTSD postmortem brain bank with a small cohort of
currently available cases (n = 6; [five females and one male] and controls n = 6; (six females)
and have conducted a microarray study of these subjects and matched controls. This has
resulted in identification of a number of dysregulated genes in the PFC of PTSD subjects, one
of which is serum and stress activated kinase 1 (SGK1). Further studies in rodent models dem-
onstrate that disruption of SGK1 signaling results in behavioral and morphological endophe-
notypes associated with traumatic stress, including helplessness- and anhedonic-like behaviors
and decreased spine density in mPFC neurons.
Results
To identify transcriptional alterations that could contribute to traumatic stress in the PFC, we
conducted a whole genome array of postmortem PFC samples collected from a small cohort of
individuals diagnosed with PTSD and age-matched individuals without psychiatric diagnoses
(S1 Table). The microarray study identified 231 down-regulated and 42 up-regulated genes in
the PFC of PTSD subjects (S2 Table). One of the most highly dysregulated genes is SGK1,
which is reported to be induced by corticosteroid hormones and has been implicated in cellular
responses to stress [17,18]. SGK1 belongs to the serine/threonine family of protein kinases con-
sisting of three isoforms, SGK1, SGK2 and SGK3 [18,19]. Our array analysis using the false dis-
covery rate (FDR) method for multiple comparisons [20] shows that SGK1 expression is
SGK1 and Traumatic Stress
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down-regulated by over 80% in PFC from PTSD subjects relative to the control group (Fig 1A).
Levels of SGK2 and SGK3 expression were also decreased relative to controls, although the
microarray results were not significant (Fig 1A). Quantitative PCR analysis was used to verify
the microarray findings and demonstrates that expression levels of SGK1, as well as SGK2 and
SGK3, are significantly decreased in the PFC of PTSD subjects (Fig 1B and S3 Table). Several
other stress- and glucocorticoid-regulated proteins were also examined, although only the glu-
cocorticoid receptor DNA binding factor 1 (GRLF1) was significantly altered in the PFC of
PTSD subjects (Fig 1C). Previous studies have reported that FKBP5 levels are decreased [21] or
increased [22] in blood or lymphocytes of PTSD patients. In our microarray study, FKBP5
expression was down-regulated in PTSD samples, but this result did not pass FDR for signifi-
cance. Out of three SGK isoforms, we decided to investigate SGK1, as it is the only gene among
the three SGK family members that is transcriptionally regulated by glucocorticoids [23–25].
In addition, SGK1 is known to regulate the function of transcription factors, ion channels, and
ion carriers and is reported to play a role in cellular and behavioral models of learning and
memory [23].
To investigate the effects of SGK1 on rodent behavior, we used a rat inescapable stress para-
digm that has been employed in rodent studies of depression but that also models some fea-
tures of PTSD [23,24]. In this paradigm, exposure to acute foot shock stress results in loss of
escape behavior, referred to as helplessness. After a series of inescapable foot shocks on day 1,
rats were tested in active avoidance on day 4. Approximately half of the animals failed to escape
the foot shocks, consistent with previous reports in outbred animals [25]. These animals are
referred to as the low-escape group (>12 or more failures). The remaining animals learned to
escape and are referred to as the high-escape group (<12 failures) (Fig 2A). There was a signifi-
cant decrease in SGK1 protein levels in PFC (dissections included prelimbic, infralimbic, and
cingulate PFC) of low-escape rats, compared to naïve, similar to the decrease in PTSD subjects
(Fig 2B). We also observed decreased SGK1mRNA, but not protein levels in the hippocampus
Fig 1. SGK1 expression is significantly decreased in the prefrontal cortex of PTSD patients. (A)
Microarray gene expression analysis of postmortem dorsolateral PFC (DLPFC) samples collected from
patients with PTSD shows decreased levels of SGK1mRNA. Microarray analysis demonstrates that levels of
SGK2 and SGK3 isoforms are reduced, but these effects were not significant. (B) Real-time qPCR was
conducted to verify the microarray findings. Data are expressed as a mean fold change ± standard error of
the mean (SEM) (n = 6), compared to healthy controls (n = 6). [t(10) = 5.966 for SGK1; t(8) = 4.275 for SGK2; t
(8) = 2.057 for SGK3, Student’s t test, *p < 0.05, **p < 0.01, ***p < 0.001]. (C) Expression levels of stress-
and glucocorticoid-regulated genes were also examined. Changes are shown as a mean fold change.
Asterisk indicates a significant p-value (*p < 0.05, FDR adjusted). For underlying data, see S1 Data. NR3C1,
glucocorticoid receptor; NR3C2, mineralocorticoid receptor; GMEB1, glucocorticoid modulatory element
binding protein 1; GRLF1, glucocorticoid receptor DNA binding factor 1; CRH, corticotropin-releasing
hormone; CRHR1, corticotropin-releasing hormone receptor 1; CRHR2, corticotropin-releasing hormone
receptor 2; CRHBP, corticotropin-releasing hormone binding protein; UCN, urocortin; UCN3, stresscopin
(urocortin 3); FKBP5, FK506 binding protein 5.
doi:10.1371/journal.pbio.1002282.g001
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(S1 Fig). As SGK1 expression is induced by glucocorticoids, we measured protein levels of glu-
cocorticoid receptor (GR) in the PFC and found no significant changes between naïve, high-,
and low-escape rats (S2 Fig). We also found that levels of postsynaptic density protein-95
(PSD-95) were significantly lower in the low-escape group compared to naïve or high-escape
rats (Fig 2C). Levels of GluR1, an ionotropic glutamate receptor, were also reduced, but not sig-
nificantly, in the low-escape group (Fig 2C). Plasma corticosterone levels were slightly elevated
in high- and low-escape animals compared to control but did not reach significance (S3 Fig).
To determine whether the behavioral differences between the low- and high-escape groups
are due to decreased SGK1 activity, we developed an approach to inhibit SGK1 function by
viral expression of a dominant negative form of SGK1 (SGK1 S422A, referred to as dnSGK1).
Enhanced green fluorescent protein (EGFP) and/or dnSGK1 were expressed under the regula-
tion of the synapsin I promoter using recombinant adeno-associated virus (rAAV) (Fig 3A and
S5 Fig). rAAV-dnSGK1 or rAAV-EGFP control viruses were infused into the mPFC of rats,
and after 3 wk to allow for optimal viral expression, they were assessed in behavioral models
according to the timeline shown in Fig 3B. Expression and location of the infusion were con-
firmed by analysis of EGFP (Fig 3C). Infusions of rAAV-dnSGK decreased Ser133 phosphory-
lation of cAMP response element-binding protein (CREB), a direct SGK1 phosphorylation
target, demonstrating the functional consequences of dominant negative SGK expression (Fig
3D and 3E). Studies in primary cultures demonstrate that dnSGK1 does not influence total
CREB levels (S6 Fig), consistent with previous reports [26], indicating that decreased phospho-
CREB (pCREB) is due to decreased phosphorylation of CREB, not total CREB levels. In the
absence of prior foot shock stress, rats infused with rAAV-dnSGK1 displayed significantly
fewer escapes compared to rAAV-EGFP controls (Fig 3F), similar to the low-escape group
exposed to foot shock stress. In contrast, infusion of rAAV-overexpressing SGK1 (referred to
as wtSGK1) resulted in a higher number of escapes in this paradigm (Fig 3J). rAAV-dnSGK1
rats also displayed significantly decreased preference for a sweetened sucrose solution, an indi-
cation of anhedonia (Fig 3G). There was no difference in total fluid consumption (Fig 3H) or
locomotor activity (Fig 3I) between groups. These studies demonstrate that inhibition of SGK1
Fig 2. SGK1 expression is altered in learned helplessness. (A) Rats were exposed to inescapable shock
(day 1), tested in active avoidance (AA) (day 4), and then sacrificed (day 8) as indicated. Animals were
separated into low- and high-escape groups according to their performance in AA test. Data are the
mean ± SEM [t(12) = 14.39, Student’s t test, ****p < 0.0001]. (B) SGK1 and (C) PSD-95 protein levels in
dissected PFC are decreased in the low-escape group. Data are mean ± SEM percent change over control
group (naive, n = 5; high escape, n = 5; low escape, n = 9), One-way ANOVA with post hoc Bonferroni test: F
(2,16) = 3.373 for SGK1 and F(2,16) = 3.704 for PSD-95, * p < 0.05. For underlying data, see S1 Data.
doi:10.1371/journal.pbio.1002282.g002
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is sufficient to cause helplessness- and anhedonic-like behaviors. Infusions of rAAV-dnSGK1
compared to rAAV-EGFP had no significant effects on behavior in anxiety-based models,
including the elevated plus maze, novelty-suppressed feeding, and open field (note that
rAAV-EGFP control and rAAV-dnSGK1 rats displayed short center time in the open field,
which could occlude any further decrease that would be suggestive of increased anxiety) or
forced swim test (S4 Fig).
To further analyze the role of SGK1 in relation to PTSD, we used fear conditioning and
extinction as another model of PTSD-related behavior that can be tested in animals [27,28].
Fig 3. Viral expression of dnSGK1 increases escape failures. (A) rAAV construct used to express dnSGK1/EGFP or EGFP alone (control). ITR, inverted
terminal repeats; IRES, internal ribosomal entry site. (B) Experimental timeline for behavioral analysis after bilateral mPFC infusions of rAAV-EGFP, rAAV-
dnSGK1, or rAAV-wtSGK1. SPT, sucrose preference test; LA, locomotor activity. (C) Shown is a representative low-power magnification of green fluorescent
protein (GFP) expression in the medial PFC after infusion of rAAV-dnSGK1. Expression was observed in the prelimbic (PrL) and infralimbic (IL) regions of the
medial PFC. Scale bar = 500 μm. (D) Colocalization of dnSGK1 and phospho-CREB (pCREB) in the prefrontal cortex: pCREB Ser133 immunostaining in rat
PFC from animals infused with rAAV-control and rAAV-dnSGK1. (E) Quantification of pCREB-positive cells showed an 18% reduction in the
dnSGK1-overexpressing group (rAAV-control, n = 16 neurons; rAAV-dnSGK1, n = 16 neurons; two rats per group). Data are mean ± SEM percent change
over control group. (rAAV-control 100 ± 5.58; rAAV-dnSGK1 82.55 ± 4.09.) (t(30) = 2.094, *p < 0.05, Student’s t test.) Effects of rAAV-dnSGK1 infusion into
medial PFC on behavior were tested in (F) AA (escape failures), (G) sucrose preference, (H) total fluid consumption, and (I) locomotor activity. Data are
shown as mean ± SEM (controls n = 11; dnSGK1 n = 9). (t(18) = 2.61 for AA and t(18) = 2.795 for SPT, Student’s t test, *p < 0.05]. (J) AA (escape failures) for
rAAV-wtSGK1 injected rats (controls n = 10; wtSGK1 n = 10). (t(18) = 1.933, one-tailed Student’s t test, *p < 0.05.) For underlying data, see S1 Data.
doi:10.1371/journal.pbio.1002282.g003
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First, rAAV-dnSGK1 or rAAV-EGFP control virus were infused into the mPFC. After 4 wk,
rats were subjected to an auditory fear conditioning and extinction paradigm (Fig 4A). Rats
were fear conditioned (day 3) and then underwent extinction training (day 4) and recall testing
(day 5) in a contextually distinct environment from that used for conditioning. During the
extinction training session, there was no significant difference in levels of conditioned stimulus
(CS)-elicited freezing between the dnSGK1 and EGFP controls (Fig 4B), indicating a similar
rate and magnitude of extinction between both groups. Twenty-four hours later, the rats were
returned to the extinction context in order to assess extinction recall (day 5, Fig 4C). The
dnSGK1-expressing rats did not show significantly higher levels of overall freezing compared
to EGFP controls, indicating that inhibition of SGK1 did not affect the acquisition of extinction
or impair the consolidation of extinction learning. Twenty-four hours after the extinction recall
session, the animals were reexposed to the context in which they were fear conditioned to
examine context-dependent fear (day 6, Fig 4D). Rats infused with rAAV-dnSGK1 displayed
higher levels of freezing compared to EGFP controls during the first 4 min of contextual mem-
ory recall test (Fig 4D), although there was no effect during the second block of 4 min. Taken
together, the results demonstrate that inhibition of SGK1 enhances the memory of contextual
cues associated with fear conditioning.
To examine the cellular mechanisms underlying these behavioral effects of SGK1 inhibition,
levels of synaptic density and function were analyzed in rat mPFC and in primary neuronal
cultures. In our initial studies of SGK1 expression in the learned helplessness model, we
observed decreased levels of the synaptic protein PSD-95 and a trend for decreased levels of the
glutamate receptor GluR1 in the low-escape group (Fig 2C), suggesting that the number of
functional spine synapses may be altered in low-escape rats. To directly test this possibility, we
examined the influence of SGK1 inhibition on dendritic spines of layer II/III pyramidal neu-
rons in mPFC. Infusion of rAAV-dnSGK1 into the mPFC significantly decreased the density of
spines on the dendrites of layer II/III neurons compared to animals receiving control virus
Fig 4. Influence of viral expression of dnSGK1 on contextual memory recall. (A) Rats were infused with rAAV-dnSGK1 or rAAV-EGFP into the mPFC.
Four weeks post infusion rats underwent auditory fear conditioning and then extinction training and testing according to the timeline schedule shown. (B)
During extinction training, CS-elicited freezing was comparable between the dnSGK1 and EGFP groups (effect for group F(1,18) = 0.7033, p = 0.4127; for
trial F(9,162) = 23.15, p < 0.0001; interaction F(9,162) = 0.3374, p = 0.9613, two-way repeated measures ANOVA). (C) During extinction recall, there was no
significant difference in freezing between dnSGK1 and controls (effect for group F(1,18) = 0.01975, p = 0.8898; for trial F(4,72) = 20.27, p < 0.0001;
interaction F(4,72) = 0.7638, p = 0.5523, two-way repeated measures ANOVA). (D) When reexposed to the original context, rats infused with dnSGK1
showed significantly higher freezing during the first 4 min of testing (t(18) = 1.787, one-tailed Student’s t test, *p < 0.05), but not during the second 4-min
block. For underlying data, see S1 Data.
doi:10.1371/journal.pbio.1002282.g004
SGK1 and Traumatic Stress
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(Fig 5A–5C). This indicates that SGK1 is necessary for maintaining the structural integrity of
dendritic spines in the PFC. Studies in primary neuronal cultures (14–16 days in vitro [DIV])
further demonstrate that rAAV-dnSGK1 significantly decreases the number of spines on apical
dendrites of neurons (Fig 6A and 6B) as well as the function of spine synapses, demonstrated
by a reduction of the amplitude (43%) and frequency (36%) of miniature evoked-postsynaptic
currents (mEPSCs) (Fig 6C–6E). These in vivo and in vitro findings suggest that the reduction
in spine number and function associated with decreased SGK1 expression could contribute to
the structural changes of PFC in PTSD patients [29,30] and to the loss of PFC inhibitory con-
trol of connected target regions [27,28].
Discussion
Whole genome microarray analysis demonstrates altered expression of a number of genes in
postmortem PFC of PTSD subjects. Based on magnitude of change and potential functional
impact in response to stress and trauma, we chose SGK1 as a candidate that could contribute to
the pathophysiology of PTSD. A recent report describes the role of SGK1 in cortisol-induced
reduction of progenitor cell proliferation in the hippocampus and enhancing GR function [31],
both of which would be relevant to depression. However, in the PFC, SGK1 expression is not
reported to be altered in MDD [32] subjects, indicating possible specificity for PTSD. In addi-
tion, the reduction of SGK1 expression in animals that display decreased escape behavior in the
learned helplessness model is consistent with the possible role of SGK1 in traumatic stress.
However, because of the small cohort of PTSD postmortem subjects (five females and one
male) that were analyzed, this finding must be replicated with additional PTSD subjects and
better representation of both sexes when samples become available to confirm a role of SGK1
in PTSD. In particular, comparison between PTSD subjects versus those exposed to trauma but
with no PTSD diagnosis would be of particular interest, as this comparison would be the most
informative in identifying key genes involved in the behavioral deficits observed in PTSD
patients.
Fig 5. Impact of dnSGK1 overexpression on spine density in the medial PFC. rAAV-dnSGK1was
infused into the medial PFC of rats, and 3 wk later, tissue was collected for analysis of spine density. (A) Low-
power image of EGFP labeled layer II/III pyramidal neurons. Scale bar = 500 μm. (B) High-power image of
representative dendrite segments taken from rAAV-control or rAAV-dnSGK1 showing altered spine number.
Scale bar = 4 μm. (C) Spine density analysis of layer II/III pyramidal dendrite segments sampled from rAAV-
dnSGK1 injected mPFC (mostly prelimbic cortex) (animals, n = 5; branches, n = 10, total dendritic
length = 347.81 μm) or rAAV-EGFP (animals, n = 7; branches, n = 14, total dendritic length = 404.46 μm).
Data are shown as mean ± SEM compared to the rAAV-EGFP control group (t(22) = 1.777, Student’s t test,
*p < 0.05). For underlying data, see S1 Data.
doi:10.1371/journal.pbio.1002282.g005
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The results also demonstrate that inhibition of SGK1 in the mPFC causes behavioral deficits
characteristic of traumatic stress. We used learned helplessness, a paradigm often employed for
studies of depression, because the behavioral deficits are induced by traumatic stress and
because helplessness is often associated with PTSD [33].
Given the high comorbidity between MDD and PTSD and the fact that exposure to trauma
is a risk factor for MDD as well as PTSD, it has been suggested that pathways mediating
learned helplessness are activated in multiple disorders induced by uncontrollable stress,
including PTSD and MDD [34].
Supporting the utility of this model, we found that a subgroup of rats that showed decreased
avoidance (i.e., helpless-like behavior) also expressed lower levels of SGK1mRNA and protein,
similar to the deficits observed in PTSD postmortem subjects. We directly tested the role of
SGK1 in helpless-like behavior using a viral vector and found that overexpression of a domi-
nant negative form of SGK1 in the mPFC reproduced the deficit in active avoidance observed
in animals exposed to inescapable stress. In contrast, overexpression of wtSGK1 in mPFC
Fig 6. Impact of dnSGK1 overexpression on dendritic spine density and electrophysiological
properties in cultured neurons. Primary neuronal cultures were incubated with rAAV-control or rAAV-
dnSGK1, and spine density and function were analyzed (14–16 DIV). (A) Representative image of EGFP
labeling in primary neurons exposed to control virus. Scale bar = 25 μm. (B) Quantitation of spines density
showing a decrease in neurons cultured with dnSGK1 (neurons, n = 6; branches, n = 7; total dendritic
length = 174.36 μm) as compared to EGFP control (neurons, n = 5; branches, n = 7; total dendritic
length = 197.95 μm). Data are shown as mean ± SEM, compared to the control group (t(12) = 3.24, Student’s
t test, **p < 0.01]. (C) Analysis of spontaneous mEPSCs (representative recording traces) in hippocampal
primary neurons (16 DIV) overexpressing dnSGK1 (n = 7) showed a decrease in amplitude (D) and frequency
(E) of mEPSCs compared to EGFP controls (n = 6). Data are shown as mean ± SEM, compared to the control
group (t(11) = 4.335, **p < 0.01 for the amplitude; t(11) = 2.738, *p < 0.05 for the frequency, Student’s t test).
For underlying data, see S1 Data.
doi:10.1371/journal.pbio.1002282.g006
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increased the number of escapes in the AA paradigm, compared to control group. We also
found that expression of dnSGK1 in the mPFC caused anhedonic-like behavior (i.e., decreased
preference for a sweet solution). These studies demonstrate that inhibition of SGK1 is sufficient
to cause helplessness- and anhedonic-like behaviors reported in PTSD [33].
Another hallmark of PTSD is the inability to extinguish or inhibit maladaptive fear responses
to stimuli previously associated with a traumatic event, even when there is no possibility for
recurrence of the trauma.We found that overexpression of dnSGK1 in the PFC enhanced freez-
ing in a context in which the rats had been fear conditioned. These findings demonstrate the
functional impact of SGK1 for proper processing of context-associated fear memory. Recent
studies showed the importance of mPFC not only for contextual fear conditioning but also for
expression of contextual fear [35,36]. These processes require mPFC activity and N-methyl-D-
aspartate (NMDA) receptor activation [37,38]. Our findings are consistent with a previous report
demonstrating that impaired fear inhibition is a specific marker of PTSD [39].
We also examined the possibility that inhibition of SGK1 causes cellular deficits that could
underlie the behavioral changes that were observed. SGK1 is reported to influence the mor-
phology of oligodendrocytes in mouse corpus callosum in response to stress [40]. We found
that viral expression of dnSGK1 in the mPFC significantly decreased the density of spines on
layer II/III pyramidal neurons compared to controls. Studies in primary neuronal cultures
(hippocampus) showed that inhibition of SGK1 produced a similar decrease in the density as
well as function of spine synapses (i.e., decreased mEPSCs), although these findings must be
confirmed in primary cortical cultures. Together these findings indicate that normal levels of
SGK1 are necessary to maintain the structural and functional integrity of spine synapses in the
PFC. Moreover, the reduction in spine number and function associated with decreased SGK1
expression could contribute to the structural changes of PFC in PTSD patients [29,30] and to
the loss of PFC inhibitory control of amygdala that is required for the extinction of fear mem-
ory in animals and humans [27,28]. Further studies will be required to determine the func-
tional impact of decreased SGK1 in vivo and to determine the underlying mechanisms by
which SGK1 influences synaptic density and function, such as regulation of the insertion of
synaptic glutamate receptors. For example, SGK1 is reported to inhibit stress-induced potentia-
tion of glutamatergic transmission through regulation of NMDA and AMPA, α-amino-
3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor trafficking, as well as to pro-
duce more long-term effects via regulation of transcription factors [17,41,42].
In summary, the results of this study demonstrate that SGK1 expression is decreased in the
postmortem PFC of a small cohort of PTSD subjects, a finding that must be confirmed in addi-
tional PTSD subjects. In addition, studies are currently underway to examine levels of SGK1 in the
blood cells of PTSD patients as well as to test for association of SGK1 polymorphisms in PTSD. It
is possible that SGK1may serve as a potential clinical biomarker for PTSD, as recently described
for pituitary adenylate cyclase-activating polypeptide (PACAP) [43], which was also shown to con-
tribute to behavioral changes observed in LH [44]. Finally, identification of downstream targets of
SGK1 could contribute to a better understanding of the molecular mechanisms underlying the
observed behavioral deficits and provide targets for novel PTSD therapeutic medications.
Materials and Methods
Ethics Statement
Postmortem brain samples were obtained from the Stanley Medical Group Brain bank, which
was responsible for consent from next of kin. All animal procedures were in accordance with
United States National Institutes of Health standards and approved by the Yale University
Institutional Animal Care and Use Committee (Protocol number: Yale IACUC #2014–07235).
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Human Subjects
The study includes total RNA samples obtained postmortem from six patients diagnosed with
PTSD (using DMS-IV criteria) and six age-matched healthy subjects.
Microarray Analysis
Brains from patients diagnosed with PTSD were matched to brains from healthy subjects based
on sex, race, and age. Human Exonic Evidence-Based Oligonucleotide (HEEBO) microarrays
(Microarrays, Nashville, Tennessee) were used to analyze changes in gene expression within
the PFC. Four μg of total RNA (RIN> 5.0, A260/280> 2.0) from PTSD (n = 6) and matched
control human samples (n = 6) were reverse transcribed into cDNA and indirectly labeled with
highly sensitive fluorescent technology (Genisphere, Hatfield, Pennsylvania). The whole
genome expression analysis was performed using two-channel MI Ready microarrays (Micro-
array, Huntsville, Alabama). Arrays contained 70-mer oligonucleotide probes from HEEBO.
First, cDNA was applied on the array chip overnight to allow hybridization. Next, chips went
through a series of washes to minimize nonspecific binding and then were labeled with fluores-
cent Cy3 and Cy5 dendrimers. After posthybridization washes, the array chips were scanned
using a GenePix scanner (Axon Instruments, Union City, California), and image analysis was
performed using GenePix Pro 6.0 software (Axon Instruments). Statistical expression analysis
of microarray image files was performed using GeneSpring GX 7.3.1 software (Silicon Genetics,
Redwood City, California). One sample from the control group had to be excluded from the
analysis because of poor hybridization. Raw values were normalized to both control channel
values (per spot) and to positive control genes (per chip). The level of regulation for an individ-
ual gene was calculated by taking the log ratio of the median experimental channel signal to the
median control channel signal. Down-regulated genes were identified by an average expression
ratio of<0.77-fold, while up-regulated genes were defined as having an average expression
ratio of>1.3-fold. Statistical analysis was performed by an unpaired t-test without using a
cross gene error model within the GeneSpring software. Statistical significance was considered
to be p 0.05 with Benjamini and Hochberg FDR as the correction for multiple testing.
Quantitative Real-Time PCR (qPCR)
Five hundred ng of total RNA extracted from human PFC tissue (six PTSD patients and six
control subjects) was reverse transcribed into cDNA using oligo-dT primers (Genisphere, Hat-
field, Pennsylvania). Real-time PCR (qPCR) was performed utilizing a hot-start SYBR Green
method with an ABI 7900 instrument (Applied Biosystems, Foster City, California) with the
following conditions: 2 s at 94°C (denaturation), 30 s at 60°C (annealing), and 30 s at 72°C
(elongation), for 40 cycles, using a Quantitect SYBR Green PCR kit (Qiagen, Valencia, Califor-
nia). All primers were designed using Primer3 v. 0.4.0 software (http://bioinfo.ut.ee/primer3-0.
4.0/primer3/; Whitehead Institute for Biomedical Research, Cambridge, Massachusetts), and
their specificity was verified using nucleotide blast software (BLAST Interface, NCBI). SGK1
gene fold changes in PTSD subjects versus those in controls were determined using ΔΔCt
(Ct = cycle number at threshold) analytical method with normalization against housekeeping
genes cyclophilin and GAPDH. The sequences of qPCR primers used are as follows: SGK1 for-
ward 50- cgccggagtatctcgcacctg-30 and reverse 50-gcggcaggccatacagcatc-30; cyclophilin forward
50-caaatcagaatgggacaggtggag-30 and reverse 50-gtttgtgttgcggcctgcatttg-30; GAPDH forward 50-
cgggaaactgtggcgtgatgg-30 and reverse 50-gccagtgagcttcccgttcagc-30.
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Animals and Behavioral Experiments
Male Sprague-Dawley rats (Charles River Laboratories International) were used for all experi-
ments. All animal procedures were in accordance with US National Institutes of Health stan-
dards and approved by the Yale University Institutional Animal Care and Use Committee. For
the inescapable foot shock (IFS) and active avoidance (AA) paradigms for rAAV-wtSGK1, rats
were habituated to the chamber for 5 min and then subjected to 60 randomized 0.8 mA foot
shocks. Three days after IFS or 3 wk after PFC virus infusion, animals were tested in the AA
paradigm. The results are expressed as the number of escape failures or the number of times
that the animal did not terminate the foot shock by making the appropriate crosses. For the
SPT, rats were habituated to 1% sucrose solution (Sigma, St. Louis, Missouri) for 48 h on day
21 post-PFC infusion. The test was performed for 1 h after 4 h deprivation in the presence of
two bottles containing 1% sucrose solution and tap water as previously described [45]. The
amounts of sucrose solution or water were measured, and the percent sucrose preference was
determined.
Novelty suppressed feeding. A novelty suppressed feeding test was conducted as previ-
ously described [46]. Briefly, rats were food deprived overnight and, on the test day, placed in
an open field (76.5 cm × 76.5 cm × 40 cm, Plexiglas) with food pellets in the center. The ani-
mals were given 15 min to approach the food and eat. The test was stopped as soon as the ani-
mal took the first bite. The latency to eat was recorded in minutes. Home cage food intake was
also measured as a control (results are presented in S4 Fig).
Elevated plus maze. The elevated plus maze consisted of two open arms (50 × 10 cm) and
two closed arms (50 × 10 × 40 cm) arranged such that the two open arms were opposite to each
other. The maze was elevated to a height of 50 cm. Rats were placed in the center of the maze
facing an open arm and were allowed to explore the maze for 10 min. The total time spent in
each arm as well as the number of entries into each arm was recorded (results are presented in
S4 Fig).
Open field. Open field test was performed in an open field (76.5 cm × 76.5 cm × 40 cm,
Plexiglas). Each rat was allowed to freely explore the open field for 10 min. Anxiety-like behav-
ior was assessed as the time spent at the periphery of the open field over a 5-min period (results
are presented in S4 Fig).
Forced swim test. A forced swim test (FST) was conducted as previously described [47].
Animals were exposed to preswim on day 1; on the next day, rats were placed in a clear cylinder
with water (24 ± 1°C, 45-cm depth) for 15 min and scored for the duration of immobility.
Immobility was defined as floating or remaining motionless without leaning against the wall of
the cylinder (results are presented in S4 Fig).
Locomotor activity. Ambulatory locomotor activity was recorded for 30 min using auto-
mated cage activity meters equipped with photocells (Digiscan animal activity monitor, Omni-
tech Electronics, Columbus, Ohio) and measured as a number of beam breaks (results are
presented in S4 Fig).
Western blot analysis. Fresh rat PFC and hippocampal tissue was homogenized in lysis
buffer (25 mMHEPES, 300 mMNaCl pH 7.4, 2% Triton-100) containing proteinase inhibitors
(Roche, Indianapolis, Indiana) and phosphatase inhibitors (10 mM NaF, 1 mM NaVO3). The
protein concentration was measured using a BCA kit (Pierce, Rockford, Illinois). Then, protein
samples were electrophoretically separated on an SDS-PAGE gel (10% Tris-HCl; Bio-Rad, Her-
cules, California) and transferred overnight to nitrocellulose membranes (0.2 μm pores; Milli-
pore, Bedford, Massachusetts). The membranes were incubated in 5% dry, nonfat milk
blocking solution (Tris-buffered saline [TBS], 0.1% Tween 20) for 1 h and then incubated at
4°C overnight with primary anti-SGK1 (1:400, Novagen), anti-PSD-95 (1:1000, Invitrogen),
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anti-GluR1 (1:1000, Abcam), anti-GR (1:1000, Santa Cruz), and anti-GAPDH (1:10000,
Advanced Immunochemical) in 1% dry nonfat milk TBST. After 3 x 15 min washes mem-
branes were incubated for 1 h with secondary, horseradish peroxidase (HRP) conjugated anti-
bodies (1:10000, Vector Laboratories, Burlingame, California). Following 3 x 15 min washes in
TBST, blots were developed using a chemilluminescence kit (Pierce, Rockford, Illinois) for 5
min and exposed onto HyBlot CL autoradiography film (Denville Scientific, Metuchen, New
Jersey). Developed blots were scanned and analyzed using ImageJ software (Scion Corp, Fred-
erick, Maryland).
For in vitro studies, E19 rat hippocampal or cortical primary cultures lysates were prepared
in the same way as described above. After SDS-PAGE, nitrocellulose membranes were incu-
bated with anti-CREB (1:1000, Cell Signaling) antibody at 4°C overnight.
Immunohistochemistry for pCREB
Sections of PFC prepared from perfused (4% paraformaldehyde) brains from rAAV-EGFP and
rAAV-dnSGK1 infused rats were blocked in 5% NGS (normal goat serum) for 1 h and incu-
bated overnight at 4°C with anti-pCREB Ser133 (1:800, Upstate) and anti-GFP (Aves Labs)
antibodies. After 3 x 15 min washes, the slices were incubated for 2 h with secondary Alexa
Fluor 488 and 546-conjugated antibodies (Jacson ImmunoResearch and Invitrogen, respec-
tively), and confocal images were collected. For quantitation of pCREB levels, a region of inter-
est (ROI = GFP positive neurons) was selected using the ImageJ program (ROI manager), first
on the GFP image (green channel). The same ROI mask was then applied to the corresponding
pCREB image (red channel) for quantitation of pCREB signal intensity. Measured intensity
values were corrected for the background nonspecific autofluorescence.
Construction, Preparation, and Infusion of Recombinant AAV
The rat SGK1 S422A cDNA (dnSGK1), followed by the IRES-EGFP expression cassette, was
cloned into an AAV2 backbone containing human Synapsin I promoter. The wtSGK1 cDNA
was cloned into AAV2 backbone under the control of Synapsin I promoter. The control rAAV
contained Synapsin IRES-EGFP expression cassette. Recombinant AAV2/1 viral stocks were
generated as described previously [48]. Briefly, HEK293 cells were transfected using Perfectin
reagent (Genlantis, San Diego, California) with AAV cis plasmid together with pDp1 and
pDp2 helper plasmids. At post-transfection day 3, cell pellets were collected and lysed in three
freeze-thaw cycles in dry ice/ethanol bath. Next, collected lysates were filtered using 0.4 μm
gauge filters and applied to HiTrap heparine HP affinity columns (GE Healthcare Bio-Sciences
AB, Uppsala, Sweden) for AAV purification. Viral titers were determined in rat hippocampal
primary cultures. For PFC virus infusions, rats were anesthetized with xylazine (6 mg/kg, IM
Lloyd laboratories, Shenandoar, Iowa) and ketamine (80 mg/kg i.m., Fort Dodge Animal
Health, Overland Park, Kansas). The virus was delivered bilaterally at +3.5 mm anterior-poste-
rior, ±0.5 mm lateral, and −4 mm ventral from the bregma [49]. Each PFC hemisphere was
infused with 3 μl of titer adjusted viral stocks at a rate of 0.2 μl per minute. Behavioral tests
were performed 3 wk after virus infusion.
Auditory Fear Conditioning and Extinction
Four identical conditioning chambers were used in all experiments (30 x 20 x 25 cm; MED-As-
sociates). Fear conditioning and extinction testing occurred in two different contexts. The con-
text was cleaned between animals using a dilute 0.9% acetic acid solution. For extinction
training and testing (in a contextually distinct environment), the appearance of the chambers
was modified, and in addition, the extinction context was further changed by cleaning the
SGK1 and Traumatic Stress
PLOS Biology | DOI:10.1371/journal.pbio.1002282 October 27, 2015 12 / 18
chambers with a 1% almond-scented solution. On days 1 and 2, the rats were habituated to the
conditioning chambers for 10-min each. On day 3, the rats were acclimated to the chambers
for 3 min. Following this, five auditory CS tones (20 s, 75 dB, 1 kHz) were presented that coter-
minated with foot shocks (1 s, 1.3 mA). The intertone interval ranged between 60 and 120 s
(mean = 78 s). On day 4, the rats underwent extinction training in a different context. After 3
min, the rats received 20 presentations of the CS alone (no US; 60 s intertone interval). Defen-
sive freezing, which was defined as the absence of observable movement except those necessary
for respiration, was scored every 3 s during presentation of the tones, and values were averaged
across two trials, resulting in ten individual CS blocks for analysis. On day 5, an extinction test
was performed in which the rats were returned to extinction context and received ten addi-
tional presentation of the CS alone. Again, freezing during the tone was scored every 3 s and
averaged across two trials resulting in five individual CS blocks for analysis. Finally, on day 6,
the rats were returned to conditioning context and an 8-min extinction test was performed, at
which time no tones or foot shocks were delivered. During the context recall test, freezing levels
was scored every 8 s during the entire 8-min test. Recordings were scored by an observer blind
to the rats’ treatment history.
Immunocytochemistry and Spine Density Analysis
Brains were perfused with 4% paraformaldehyde and sectioned using a Vibrotome (Leica). 60-
μm brain sections were blocked in 5% NGS for 1 h and incubated overnight at RT with chicken
anti-GFP primary antibody (1:400, Aves Labs). After 3 x 15 min washes, slices were incubated
for 2 h with secondary anti-chicken Alexa Fluor 488-conjugated antibody (Jacson ImmunoRe-
search). Confocal z-stacks of dendrites (distal tuft branches) were collected using Olympus
Fluoview confocal microscope with a 100x objective with constant laser intensity. Total branch
length and spine density were determined using Volocity software (Improvision) in 3D
restored confocal z-stacks (1024 x 1024 resolution) that went through deconvolution to remove
noise pixels. The analysis was performed in the blind fashion, and the spines were counted by
hand.
In Situ Hybridization
In situ hybridization was conducted according to standard previously published protocol used
in our laboratory [50]. (35S)-radiolabeled, SGK1 specific riboprobes were generated by an in
vitro transcription reaction using a PCR product-derived template and MAXIscript kit T7
polymerase (Ambion, Austin, Texas). For generation of the probe template, the following
primers (forward and reverse) were used in PCR reaction:
rSGK1 L, 50-cagagcgcaatgttctgttgaag -30;
rSGK1 L, 50-CCAAGCCTTCTAATACGACTCACTATAGGGAGAgtcccattgtgctcgatgttctc-30
The optical density was quantified within three regions of the hippocampus (CA1, CA3,
and DG) using ImageJ (NIH). Using the manufacturer’s calibration scale, specific labeling was
determined by subtracting nonspecific binding from total binding.
ELISA. Serum was extracted and analyzed using ELISA assay for corticosterone levels
according to the manufacturer’s specifications (Assay Designs, Ann Arbor, Michigan).
Hippocampal and Cortical Primary Cultures
E(18) hippocampal and cortical primary cultures were prepared from Sprague Dawley rat tis-
sue as previously described [51,52] and cultured for 2–3 wk in Neurobasal medium supple-
mented with B27 (Invitrogen).
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Electrophysiology
The protocol for measuring the spontaneous postsynaptic currents has been described previ-
ously [53]. Briefly, the currents were recorded at −70 mV by whole-cell patch-clamp at room
temperature (~25°C). Recording electrodes contained (in mM) 120 potassium gluconate, 8
NaCl, 0.5 EGTA, 10 Hepes, and 2 MgATP (pH 7.3). The external solution contained 150 NaCl,
5 KCl, 2.5 CaCl2, 5.5 Hepes-acid, 4.5 Hepes-Na, 10 glucose, and 0.1 tetrodotoxin (pH 7.3).
Hippocampal neurons (DIV 16–18) were perfused continuously over the cells, and the inward
currents were recorded at resting potential, using Clampex 8, and the data were analyzed, using
pClamp 10.2 (Molecular Devices).
Supporting Information
S1 Data. Excel file containing raw data for Figures: Figs 1A–1C, 2A–2C, 3E–3J, 4B–4D, 5C,
6B, 6D, 6E, S1A, S1B, S2B, S3, S4B–S4F, S5 and S6 Figs.
(XLSX)
S1 Fig. Expression of SGK1 in the hippocampus of rats exposed to learned helplessness. (A)
Representative autoradiographs and quantitative analysis of hippocampal SGK1 mRNA levels
determined by in situ hybridization in high- and low-escape rats. SGK1 mRNA levels in the
CA1 and CA3 pyramidal cell layers and the dentate gyrus granule cell layer were determined.
(One-way ANOVA with post hoc Bonferroni test [F(2,16) = 6,014 for CA1, F(2,16) = 3,214 for
CA3, and F(2,16) = 7,131 for DG, p< 0.05). (B) Western blot analysis of SGK1 protein levels
in rat whole hippocampal lystates prepared from high- and low-escape rats (naïve, n = 5; high
escape, n = 5; low escape, n = 9).
(TIF)
S2 Fig. Levels of glucocorticoid receptor (GR) in the prefrontal cortex of rats exposed to
learned helplessness. (A) Representative western blot and quantitative analysis of SGK1 pro-
tein levels in high- and low-escape rats (naïve, n = 5; high escape, n = 5; low escape, n = 9).
(TIF)
S3 Fig. Serum corticosterone levels in rats exposed to learned helplessness. Rats were
exposed to inescapable shock (day 1), tested in AA (day 4), and then sacrificed and blood sam-
ples were collected (day 8) (naïve, n = 5; high escape n = 5; low escape n = 9).
(TIF)
S4 Fig. Influence of dnSGK1 on anxiety-related behaviors. (A) Behavioral evaluation after
bilateral PFC infusions of rAAV-EGFP (n = 8) or rAAV-dnSGK1 (n = 10). Rats were tested in
several different anxiety-based animal models, including (B) novelty suppressed feeding (NSF),
(C) elevated plus maze (EPM), (D) open field test (OFT), as well as a model of behavioral
despair (E), the forced swim test (FST). (F) There was no difference in the locomotor activity
between the groups (LA).
(TIF)
S5 Fig. Western blot analysis of (A) dnSGK1 and (B) wtSGK1 overexpression using rAAV
in rat hippocampal primary cultures.
(TIF)
S6 Fig. Western blot analysis of total CREB levels in rat cortical primary cultures treated
with rAAV-control and rAAV-dnSGK1. Experiment was replicated three times.
(TIF)
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S1 Table. Case demographics of PTSD patients and matched healthy control subjects. F,
female; M, male; C, Caucasian; H, Hispanic; PMI, postmortem interval (hours); RIN, RNA
integrity number.
(DOCX)
S2 Table. Whole-genome expression analysis of human postmortem PFC. Complete list of
up- and down-regulated genes after FDR adjustment for p-values. Healthy controls, n = 5;
PTSD patients, n = 6.
(DOCX)
S3 Table. Real-time qPCR validation of microarray results for five additional genes.
Healthy controls, n = 5; PTSD patients, n = 6. For the microarray, asterisk indicates significant
p-value (p< 0.05, FDR adjusted). Real-time qPCR for FGFR2 t(10) = 3.272, Student’s t test,
p< 0.01.
(DOCX)
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